# Turn Therapeutics Inc.: filings TTRX · Nasdaq · CIK 2023016 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ttrx.md) · [Financials](/companies/ttrx/financials.md) · [Filings](/companies/ttrx/filings.md) · [Insiders](/companies/ttrx/insiders.md) ## Reports and events: 36 filings Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 27, 4 23, CORRESP 8, 3 7, UPLOAD 6, 1-A/A 5, C/A 4, 10-Q 3, 253G2 3, EFFECT 3, 424B3 2, C 2, C-U 2, DRS 2, POS AM 2, S-1 2, S-1/A 2, 10-K 1, 1-A 1, 1-K 1, 1-SA 1, 424B4 1, 424B5 1, 8-A12B 1, 8-A12B/A 1, ARS 1, C-AR 1, CERT 1, C-TR 1, D 1, DEF 14A 1, DRS/A 1, DRSLTR 1, QUALIF 1, S-8 1, SCHEDULE 13G 1). | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-19 | 20:05 ET | [DEF 14A](/filings/0001213900-26-110670.md) | Proxy statement, period 2026-11-30 | 0001213900-26-110670 | | 2026-10-07 | 23:30 ET | [8-K](/filings/0001213900-26-107329.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-107329 | | 2026-09-10 | 12:10 ET | [8-K](/filings/0001213900-26-098584.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-098584 | | 2026-09-09 | 12:10 ET | [8-K](/filings/0001213900-26-098224.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-098224 | | 2026-08-18 | 12:30 ET | [8-K](/filings/0001213900-26-091002.md) | 3.02 Unregistered sale of equity | 0001213900-26-091002 | | 2026-08-17 | 20:14 ET | [8-K](/filings/0001213900-26-090766.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-090766 | | 2026-08-12 | 20:50 ET | [10-Q](/filings/0001213900-26-088427.md) | Quarterly report, period 2026-06-30 | 0001213900-26-088427 | | 2026-08-12 | 20:40 ET | [8-K](/filings/0001213900-26-088411.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-088411 | | 2026-07-28 | 12:05 ET | [8-K](/filings/0001213900-26-081996.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-081996 | | 2026-07-07 | 12:05 ET | [8-K](/filings/0001213900-26-075757.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-075757 | | 2026-06-03 | 10:12 ET | [8-K](/filings/0001213900-26-064405.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-064405 | | 2026-06-01 | 12:45 ET | [8-K](/filings/0001213900-26-063177.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-063177 | | 2026-05-27 | 12:10 ET | [8-K](/filings/0001213900-26-061244.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-061244 | | 2026-05-19 | 12:15 ET | [8-K](/filings/0001213900-26-058730.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-058730 | | 2026-05-18 | 12:15 ET | [8-K](/filings/0001213900-26-058140.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-058140 | | 2026-05-11 | 20:17 ET | [10-Q](/filings/0001213900-26-054490.md) | Quarterly report, period 2026-03-31 | 0001213900-26-054490 | | 2026-05-11 | 20:10 ET | [8-K](/filings/0001213900-26-054480.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-054480 | | 2026-03-31 | 20:30 ET | [10-K](/filings/0001213900-26-037505.md) | Annual report, period 2025-12-31 | 0001213900-26-037505 | | 2026-03-31 | 20:18 ET | [8-K](/filings/0001213900-26-037470.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-037470 | | 2026-03-24 | 12:17 ET | [8-K](/filings/0001213900-26-033233.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-033233 | | 2026-02-17 | 13:10 ET | [8-K](/filings/0001213900-26-016916.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-016916 | | 2026-02-09 | 13:44 ET | [8-K](/filings/0001213900-26-013490.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-013490 | | 2026-01-12 | 13:12 ET | [8-K](/filings/0001213900-26-003153.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-003153 | | 2026-01-07 | 21:18 ET | [8-K](/filings/0001213900-26-002173.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-002173 | | 2025-11-13 | 13:05 ET | [10-Q](/filings/0001213900-25-109586.md) | Quarterly report, period 2025-09-30 | 0001213900-25-109586 | | 2025-11-13 | 13:00 ET | [8-K](/filings/0001213900-25-109580.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-109580 | | 2025-11-12 | 12:11 ET | [8-K](/filings/0001213900-25-108655.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-108655 | | 2025-11-04 | 22:26 ET | [8-K](/filings/0001213900-25-106265.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-106265 | | 2025-10-30 | 11:44 ET | [8-K](/filings/0001104659-25-104028.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-104028 | | 2025-10-28 | 20:05 ET | [8-K](/filings/0001104659-25-103160.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-103160 | | 2025-10-22 | 12:06 ET | [8-K](/filings/0001104659-25-101410.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-101410 | | 2025-10-09 | 20:15 ET | [S-1](/filings/0001104659-25-098363.md) | Registration statement | 0001104659-25-098363 | | 2025-10-02 | 18:15 ET | [8-K](/filings/0001104659-25-096003.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-25-096003 | | 2025-09-24 | 21:16 ET | [S-1/A](/filings/0001104659-25-092994.md) | Registration statement, amended | 0001104659-25-092994 | | 2025-09-16 | 21:09 ET | [S-1/A](/filings/0001104659-25-090474.md) | Registration statement, amended | 0001104659-25-090474 | | 2025-09-02 | 00:31 ET | [S-1](/filings/0001104659-25-085850.md) | Registration statement | 0001104659-25-085850 | Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.